GlaxoSmithKline (GSK - Egypt) (BIOC) said the Hikma Pharmaceuticals would not submit a Mandatory Tender Offer (MTO) to acquire GSK-Egypt, according to the company’s statement to the Egyptian Exchange.

Egyptian Starch and Glucose Company (ESGC) will write off its shares from the Egyptian Exchange (EGX) and buy back the shares from shareholders who dissented to the delisting, according to the company’s disclosure filed to the EGX.

Macro Group Pharma plans to go for an initial public offering (IPO) in the first quarter (Q1) or the second quarter (Q2) of 2021, becoming Egypt’s second IPO this year, Enterprise reported.

Listing Misr Life Company will not be ready for listing on the Egyptian Exchange (EGX) as part of the state privatization program before the end of 2021, public business sector minister Hisham Tawfik reportedly told Al Mal on March 1st.